Financhill
Back

Genmab AS Vs. Ascendis Pharma AS Industry Stock Comparison

Sell
25

GMAB
Genmab AS

Last Price:
20.48
Seasonality Move:
3.28%
Sell
20

ASND
Ascendis Pharma AS

Last Price:
122.73
Seasonality Move:
20.86%
Sell
25
Genmab AS (GMAB) is a Sell

Is Genmab AS a Buy, Sell or Hold?

  • The current Genmab AS [GMAB] share price is $20.45. The Score for GMAB is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • GMAB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
20
Ascendis Pharma AS (ASND) is a Sell

Is Ascendis Pharma AS a Buy, Sell or Hold?

  • The current Ascendis Pharma AS [ASND] share price is $124.38. The Score for ASND is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • ASND is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

GMAB Stock Price Chart

What is Genmab AS's stock price today?

  • The Genmab AS share price today is $20.45
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GMAB is experiencing slight selling pressure.

ASND Stock Price Chart

What is Ascendis Pharma AS's stock price today?

  • The Ascendis Pharma AS share price today is $124.38
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASND is experiencing slight buying pressure.

GMAB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.79 Sell
Relative Strength Index (14 RSI): 25.28 Sell
Chaikin Money Flow: -57518 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (21.45 - 23.25) Sell
Bollinger Bands (100): (23.03 - 27.51) Sell

ASND Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.98 Sell
Relative Strength Index (14 RSI): 44.33 Sell
Chaikin Money Flow: 89072 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (124.33 - 129.33) Sell
Bollinger Bands (100): (124.53 - 141.57) Sell

GMAB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.34 Sell
20-day SMA: 22.22 Sell
50-day SMA: 23.4 Sell
200-day SMA: 26.95 Sell
8-day EMA: 21.16 Sell
20-day EMA: 22 Sell
50-day EMA: 23.31 Sell
200-day EMA: 26.81 Sell

ASND Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 125.5 Sell
20-day SMA: 126.25 Sell
50-day SMA: 132.55 Sell
200-day SMA: 136.92 Sell
8-day EMA: 124.99 Sell
20-day EMA: 126.65 Sell
50-day EMA: 129.84 Sell
200-day EMA: 130.32 Sell

Genmab AS Earnings Growth & GMAB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.16 per share, and an increase next year of $0.28 per share.

Ascendis Pharma AS Earnings Growth & ASND Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.63 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.89 per share, and an increase next year of $4.01 per share.

Genmab AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ascendis Pharma AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):